Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Liver Disease Medication	4.46B
Liver Disease Medication Growth	24.26%
Pharmaceutical Circulation	4.20B
Pharmaceutical Circulation Growth	3.60%
Cosmetics	706.76M
Cosmetics Growth	11.42%
Cardiovascular and Cerebrovascular Medication	265.75M
Cardiovascular and Cerebrovascular Medication Growth	60.57%
Other Business	22.31M
Other Business Growth	14.28%
Other	395.59M
Other Growth	76.53%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	9.60B
China Growth	15.78%
Overseas	457.64M
Overseas Growth	13.95%